CIK: 0002003159
Total reported value
$24.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NMRK | Newmark Group Inc-class A | Stock-Other | 21.01% | -21.01% | EXIT | |
| 2 | CI | THE Cigna Group | Stock-Healthcare | 19.66% | -19.66% | EXIT | |
| 3 | ARVN | Arvinas INC | Stock-Other | 11.93% | +0.65% | — | |
| 4 | ABVX | Abivax Sa-adr | Stock-Other | 11.72% | -1.32% | — | |
| 5 | IQV | Iqvia Holdings INC | Stock-Healthcare | 11.15% | -11.15% | EXIT | |
| 6 | MRVI | Maravai Lifesciences Hldgs-a | Stock-Other | 8.99% | -0.04% | — | |
| 7 | BDX | Becton Dickinson And Co | Stock-Healthcare | 6.07% | -6.07% | EXIT | |
| 8 | ATAI | AtaiBeckley Inc. | Stock-Other | 5.81% | -5.81% | EXIT | |
| 9 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 2.45% | -2.45% | EXIT | |
| 10 | GRML | Greenland Mines LTD | Stock-Other | 1.06% | -0.55% | — | |
| 11 | FHTX | Foghorn Therapeutics INC | Stock-Other | 0.15% | -0.15% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BDX | Becton Dickinson And Co | +4.5% | +1001.28% | Add |
| 2 | NMRK | Newmark Group Inc-class A | -43.4% | +5.79% | Add |
| 3 | CI | THE Cigna Group | — | NEW | New buy |
| 4 | ARVN | Arvinas INC | — | NEW | New buy |
| 5 | ABVX | Abivax Sa-adr | — | NEW | New buy |
| 6 | IQV | Iqvia Holdings INC | — | NEW | New buy |
| 7 | MRVI | Maravai Lifesciences Hldgs-a | — | NEW | New buy |
| 8 | PTCT | Ptc Therapeutics INC | — | EXIT | Sold out |
| 9 | ATAI | AtaiBeckley Inc. | — | NEW | New buy |
| 10 | CIGI | Colliers Intl Gr-subord Vot | — | EXIT | Sold out |
| 11 | SLNOEUR | Soleno Therapeutics INC | — | NEW | New buy |
| 12 | GRML | Greenland Mines LTD | — | NEW | New buy |
| 13 | FHTX | Foghorn Therapeutics INC | — | NEW | New buy |